Director Dr. Fred E. Cohen to leave Progyny board after 2025 Annual Meeting

Progyny, Inc.

Dr. Cohen notified Progyny on April 9, 2025 of his decision not to stand for reelection at the 2025 Annual Meeting.
Decision unrelated to any disagreement with the Company on operations, policies, or practices.
Cohen will continue serving as director through the end of his current term at the Annual Meeting.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. Fred E. Cohen

Director

PGNY · Progyny, Inc.

Filed: April 11, 2025, 7:59 PM ET

On April 9, 2025, Dr. Fred E. Cohen notified the Board of Directors of Progyny, Inc. (the “Company”) of his decision not to stand for reelection at the Company’s 2025 Annual Meeting of Stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Fred E. Cohen departed as Director at Progyny, Inc..

Action: not stand for reelection
Role: Director

Exact text from the filing

On April 9, 2025, Dr. Fred E. Cohen notified the Board of Directors of Progyny, Inc. (the “Company”) of his decision not to stand for reelection at the Company’s 2025 Annual Meeting of Stockholders.

View on SEC.gov

Progyny, Inc. filing history →

Source: SEC EDGAR

accession 0001551306-25-000070

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.